Mosaic Immunoengineering Inc
mosaicie.comWhat Do They Do?
Develops potential immunotherapies to treat cancer and seeks to identify and advance additional product candidates.
10-K for FY2025, filed Apr 15, 2026
How Do They Make Money?
No revenue reported yet.
10-K for FY2025, filed Apr 15, 2026
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 14, 2026
−$177.5KView ↗
- ▲ +3% (Loss)
- vs −$172K in Q2 FY2025
Broader pipeline focus
The older report focused on a proprietary CPMV immunotherapy platform and its lead candidate; the latest describes pursuing new candidates and platforms, and notes the CWRU license ended.
10-K for FY2022, filed Mar 2, 2023 10-K for FY2025, filed Apr 15, 2026
Who Do They Compete With?
Competes with Amgen, AstraZeneca, Bristol-Myers Squibb, Genentech, GlaxoSmithKline, Merck &, Novartis, Pfizer, Roche Holding, and Sanofi
10-K for FY2025, filed Apr 15, 2026Competition in the pharmaceutical and biotechnology industry is intense and characterized by aggressive research and development and…View ↗
Loading...
